Loading…
Sandra-pharma.is sold unapproved new drugs and misbranded drug products intended to mitigate, prevent, treat, diagnose, or cure COVID-19 over the internet to U.S. consumers, violating sections 505(a) and 502 of the Federal Food, Drug, and Cosmetic Act. The company's products lacked FDA approval or authorization and did not carry the same safety and effectiveness assurances as FDA-regulated drugs. This enforcement action was undertaken during the declared public health emergency and national emergency related to COVID-19, when the FDA prioritized protecting consumers from unauthorized COVID-19 treatment claims.